Driehaus Capital Management LLC Kodiak Sciences Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $1.68 Million - $3.71 Million	391,028 New	391,028 $2.7 Million
Q3 2020 Nov 16, 2020	SELL	$45.05 - $59.27 $8.58 Million - $11.3 Million	-190,473 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $4.5 Million - $6.97 Million	-105,210 Reduced 35.58%	190,473 $10.3 Million
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $11.3 Million - $21.9 Million	295,683 New	295,683 $14.1 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.